Trends in psychotropic use in Saskatchewan from 1983 to 2007

Canadian Journal of Psychiatry

Volumn 58, Issue 7, 2013, Pages 426-431

  Meng, Xiangfei ^a   D'Arcy, Carl ^a   Tempier, Raymond ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Hopital Montfort Hospital   (Canada)

Author keywords

Prescriptions; Psychotropic medications; Saskatchewan; Trends

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CENTRAL STIMULANT AGENT; CHOLINESTERASE INHIBITOR; MOOD STABILIZER; PSYCHOTROPIC AGENT; STABILIZING AGENT;

ARTICLE; CANADA; GENERAL PRACTITIONER; OUTPATIENT DEPARTMENT; PRESCRIPTION; SEX;

EID: 84879939748     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371305800708     Document Type: Article

References (21)

1. Health Canada. A report on mental illness in Canada. Ottawa (ON): Health Canada; 2002.
2. Lancet Global Mental Health Group, Chisholm D, Flisher AJ, et al. Scale up services for mental disorders: a call for action. Lancet. 2007;370(9594):1241-1252.
3. Ohayon MM, Caulet M, Priest RG, et al. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol. 1998;51(3):273-283. (Pubitemid 28122077)
4. Ohayon MM, Gaulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry. 1996;41(7):457-464. (Pubitemid 26352974)
5. Mari JJ, Almeida-Filho N, Coutinho E, et al. The epidemiology of psychotropic use in the city of São Paulo. Psychol Med. 1993;23(2):467-474. (Pubitemid 23209241)
6. Zito JM, Safer DJ, de Jong-van den Berg LT, et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health. 2008;2(1):26.
7. Comer JS, Mojtabai R, Olfson M. National trends in the antipsychotic treatment of psychiatric patients with anxiety disorders. Am J Psychiatry. 2011;168(10):1057-1065.
8. Sanyal C, Asbridge M, Kisely S, et al. The utilization of antidepressants and benzodiazepines among people with major depression in Canada. Can J Psychiatry. 2011;56(11):667-676.
9. Bolton JM, Dahl M, Sareen J, et al. A population-based study of the use of selective serotonin reuptake inhibitors before and after introduction of generic equivalents. Can J Psychiatry. 2012;57(4):223-229.
10. Puyat JH, Law MR, Wong ST, et al. The essential and potentially inappropriate use of antipsychotics across income groups: an analysis of linked administrative data. Can J Psychiatry. 2012;57(8):488-495.
11. Marchildon G, O'Fee K. Health care in Saskatchewan: an analytical profile. Regina (SK): Canadian Plains Research Centre and the Saskatchewan Institute of Public Policy; 2007.
12. Rawson N, Downey W, Maxwell C, et al. 25 years of pharmacoepidemiologic innovation: the Saskatchewan Health Administrative Databases. J Popul Ther Clin Pharmacol. 2011;18(2):e245-e249.
13. Canadian Institute for Health Information (CIHI). Supply, distribution and migration of Canadian physicians, 2007. Ottawa (ON): CIHI; 2008.
14. Comer JS, Olfson M, Mojtabai R. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry. 2010;49(10):1001-1010.
15. Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010;67(1):26-36.
16. Verdichevski M, Burns R, Cunningham JK, et al. Trends in primary methamphetamine-related admissions to youth residential substance abuse treatment facilities in Canada, 2005-2006 and 2009-2010. Can J Psychiatry. 2011;56(11):696-700.
17. Beck CA, Williams JV, Wang JL, et al. Psychotropic medication use in Canada. Can J Psychiatry. 2005;50(10):605-613. (Pubitemid 43175499)
18. Lockhart P, Guthrie B. Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br J Gen Pract. 2011;61(590):e565-e572.
19. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Epidemiol. 2002;63(9):817-825.
20. Mickus M, Colenda CC, Hogan AJ. Knowledge of mental health benefits and preferences for type of mental health providers among the general public. Psychiatr Serv. 2000;51(2):199-202. (Pubitemid 30082521)
21. Gum AM, Cheavens JS. Psychiatric comorbidity and depression in older adults. Curr Psychiatry Rep. 2008;10(1):23-29. (Pubitemid 351266366)